Why is Lincoln Pharma. falling/rising?

As of 07-Aug, Lincoln Pharmaceuticals Ltd is experiencing a significant price increase, with its current price at 604.10, reflecting a rise of 72.25 or 13.58%. Today's performance indicates that the stock has outperformed its sector by 12.93% and has shown a trend reversal after two consecutive days of decline. The stock reached an intraday high of Rs 624.8, demonstrating high volatility with an intraday fluctuation of 5.18%. Additionally, the stock has shown positive momentum over the past week with a return of 12.79%, contrasting with the Sensex, which has declined by 0.69%. However, despite the recent gains, the stock is down 23.63% year-to-date compared to a 3.18% increase in the Sensex.
In the broader market context, Lincoln Pharmaceuticals' short-term performance has been notably stronger than the benchmark, as evidenced by its 1-week return of 12.79% against the Sensex's decline. This suggests that investor sentiment may be shifting positively towards the stock, particularly with rising delivery volumes and increased investor participation. The stock's liquidity remains adequate for trading, which could further support its upward movement. Overall, while the stock has faced challenges in the longer term, the recent surge in price and positive trading activity indicate a potential recovery phase amidst a generally unfavorable market backdrop.